Bexotegras is a small-molecule active pharmaceutical ingredient that functions as a dual inhibitor of integrins αvβ6 and αvβ1. It is under clinical investigation for conditions involving fibrosis and inflammation, including idiopathic pulmonary fibrosis and primary sclerosing cholangitis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Bexotegras?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Probenecid sodium
pharmaceutical raw material
Retatrutide
pharmaceutical raw material
Ambroxol hydrochloride
pharmaceutical raw material
Carbocisteine
pharmaceutical raw material
The international HS code for Bexotegras (CAS 2376257-44-0) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(quinazolin-4-ylamino)butanoic acid
CWOFQJBATWQSHL-DEOSSOPVSA-N
COCCN(CCCCC1=NC2=C(CCCN2)C=C1)CC[C@@H](C(=O)O)NC3=NC=NC4=CC=CC=C43
Sourcing Bexotegras?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.